Tumour-released exosomes and their implications in cancer immunity

M. Iero, R. Valenti, V. Huber, P. Filipazzi, G. Parmiani, S. Fais, L. Rivoltini

Research output: Contribution to journalArticle

336 Citations (Scopus)

Abstract

Tumour cells release vesicular structures, defined as microvesicles or exosomes, carrying a large array of proteins from their originating cell. The expression of antigenic molecules recognized by T cells has originally suggested a role for these organelles as a cell-free antigen source for anticancer vaccines. However, recent evidence shows that tumour exosomes may also exert a broad array of detrimental effects on the immune system, ranging from apoptosis in activated antitumour T cells to impairment of monocyte differentiation into dendritic cells and induction of myeloid suppressive cells. Immunosuppressive exosomes of tumour origin can be found in neoplastic lesions and sera from cancer patients, implying a potential role of this pathway in in vivo tumour progression. Through the expression of molecules involved in angiogenesis promotion, stromal remodelling, delivery of signalling pathways through growth factor/receptor transfer, chemoresistance and genetic intercellular exchange, tumour exosomes could represent a versatile tool for moulding host environment. Hence, their secretion by neoplastic cells may in the future become a novel pathway to target for therapeutic intervention in cancer patients.

Original languageEnglish
Pages (from-to)80-88
Number of pages9
JournalCell Death and Differentiation
Volume15
Issue number1
DOIs
Publication statusPublished - Jan 2008

Fingerprint

Exosomes
Immunity
Neoplasms
T-Lymphocytes
Protein Array Analysis
Growth Factor Receptors
Myeloid Cells
Immunosuppressive Agents
Organelles
Dendritic Cells
Monocytes
Immune System
Vaccines
Apoptosis
Antigens
Serum

ASJC Scopus subject areas

  • Cell Biology

Cite this

Tumour-released exosomes and their implications in cancer immunity. / Iero, M.; Valenti, R.; Huber, V.; Filipazzi, P.; Parmiani, G.; Fais, S.; Rivoltini, L.

In: Cell Death and Differentiation, Vol. 15, No. 1, 01.2008, p. 80-88.

Research output: Contribution to journalArticle

Iero, M. ; Valenti, R. ; Huber, V. ; Filipazzi, P. ; Parmiani, G. ; Fais, S. ; Rivoltini, L. / Tumour-released exosomes and their implications in cancer immunity. In: Cell Death and Differentiation. 2008 ; Vol. 15, No. 1. pp. 80-88.
@article{0fc221c3ed8c405daea6119325d3c9cd,
title = "Tumour-released exosomes and their implications in cancer immunity",
abstract = "Tumour cells release vesicular structures, defined as microvesicles or exosomes, carrying a large array of proteins from their originating cell. The expression of antigenic molecules recognized by T cells has originally suggested a role for these organelles as a cell-free antigen source for anticancer vaccines. However, recent evidence shows that tumour exosomes may also exert a broad array of detrimental effects on the immune system, ranging from apoptosis in activated antitumour T cells to impairment of monocyte differentiation into dendritic cells and induction of myeloid suppressive cells. Immunosuppressive exosomes of tumour origin can be found in neoplastic lesions and sera from cancer patients, implying a potential role of this pathway in in vivo tumour progression. Through the expression of molecules involved in angiogenesis promotion, stromal remodelling, delivery of signalling pathways through growth factor/receptor transfer, chemoresistance and genetic intercellular exchange, tumour exosomes could represent a versatile tool for moulding host environment. Hence, their secretion by neoplastic cells may in the future become a novel pathway to target for therapeutic intervention in cancer patients.",
author = "M. Iero and R. Valenti and V. Huber and P. Filipazzi and G. Parmiani and S. Fais and L. Rivoltini",
year = "2008",
month = "1",
doi = "10.1038/sj.cdd.4402237",
language = "English",
volume = "15",
pages = "80--88",
journal = "Cell Death and Differentiation",
issn = "1350-9047",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Tumour-released exosomes and their implications in cancer immunity

AU - Iero, M.

AU - Valenti, R.

AU - Huber, V.

AU - Filipazzi, P.

AU - Parmiani, G.

AU - Fais, S.

AU - Rivoltini, L.

PY - 2008/1

Y1 - 2008/1

N2 - Tumour cells release vesicular structures, defined as microvesicles or exosomes, carrying a large array of proteins from their originating cell. The expression of antigenic molecules recognized by T cells has originally suggested a role for these organelles as a cell-free antigen source for anticancer vaccines. However, recent evidence shows that tumour exosomes may also exert a broad array of detrimental effects on the immune system, ranging from apoptosis in activated antitumour T cells to impairment of monocyte differentiation into dendritic cells and induction of myeloid suppressive cells. Immunosuppressive exosomes of tumour origin can be found in neoplastic lesions and sera from cancer patients, implying a potential role of this pathway in in vivo tumour progression. Through the expression of molecules involved in angiogenesis promotion, stromal remodelling, delivery of signalling pathways through growth factor/receptor transfer, chemoresistance and genetic intercellular exchange, tumour exosomes could represent a versatile tool for moulding host environment. Hence, their secretion by neoplastic cells may in the future become a novel pathway to target for therapeutic intervention in cancer patients.

AB - Tumour cells release vesicular structures, defined as microvesicles or exosomes, carrying a large array of proteins from their originating cell. The expression of antigenic molecules recognized by T cells has originally suggested a role for these organelles as a cell-free antigen source for anticancer vaccines. However, recent evidence shows that tumour exosomes may also exert a broad array of detrimental effects on the immune system, ranging from apoptosis in activated antitumour T cells to impairment of monocyte differentiation into dendritic cells and induction of myeloid suppressive cells. Immunosuppressive exosomes of tumour origin can be found in neoplastic lesions and sera from cancer patients, implying a potential role of this pathway in in vivo tumour progression. Through the expression of molecules involved in angiogenesis promotion, stromal remodelling, delivery of signalling pathways through growth factor/receptor transfer, chemoresistance and genetic intercellular exchange, tumour exosomes could represent a versatile tool for moulding host environment. Hence, their secretion by neoplastic cells may in the future become a novel pathway to target for therapeutic intervention in cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=37349012215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349012215&partnerID=8YFLogxK

U2 - 10.1038/sj.cdd.4402237

DO - 10.1038/sj.cdd.4402237

M3 - Article

C2 - 17932500

AN - SCOPUS:37349012215

VL - 15

SP - 80

EP - 88

JO - Cell Death and Differentiation

JF - Cell Death and Differentiation

SN - 1350-9047

IS - 1

ER -